StocksIntellia Therapeutics IncNTLA

NTLA

Intellia Therapeutics Inc

69.45 2.17 (3.23%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
NTLA
NTLA
FeedStatsChartResearch
S
69.45
B
69.65

Intellia Therapeutics Inc

Intellia Therapeutics Inc. (formerly known as AZRN Inc.) was founded in 2014 and is headquartered in Cambridge, Massachusetts. The company is currently focused on gene editing and the development of therapeutics based on a unique biological tool called CRISPR/Cas9 system. Company products are meant to... Show More
Last Month
20,639
Followers
1.19%
Investors
100% Of them have BUY positions.
A decrease of -0.40% from last trading Day

Related Markets

Sunny Optical Technology Group
02382.HK
6.19 (3.26%)
S
196.02
B
196.48
Spie SA
SPIE.PA
-0.08 (-0.39%)
S
20.62
B
20.68
Mettler-Toledo International Inc
MTD
34.23 (2.68%)
S
1309.26
B
1312.72
Aker BP ASA
AKERBP.OL
-2.30 (-1.00%)
S
227.99
B
228.61
Countryside Properties PLC
CSP.L
3.50 (0.67%)
S
522.53
B
524.47
View More

Investors

View More
Top
Clement Victor Gonzalez
France
2 days ago
Edited
๐Ÿ“‰ WHY EDITAS MEDICINE SELLOFF LOOKS OVERDONE? ๐Ÿ”ธ What Happened to the stock? The shares of Editas Medicine dropped more than 15% last Friday, after Goldman Sachs initiated coverage on $EDIT (Editas Medicine Inc) stock with a โ€œSellโ€ rating and a $20 price target. At the time, the stock price was around... Show More
Like CommentShare
Show more comments2 of 3
1 reply
null
<